Loading
Melanotan II · research summary
Endocrinology · 2024. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.
Investigation of therapeutic strategies for hyperphagia and obesity in mice with Htr2c gene mutations
“In this study, we aimed to investigate the potential therapeutic strategies for ameliorating hyperphagia, hyperglycemia, and obesity associated with a loss-of-function mutation in the Htr2c gene (Htr2cF327L/Y).”
Htr2cF327L/Y mice subjected to a high-fat diet
“We demonstrated that reexpressing functional 5-HT2CR solely in hypothalamic pro-opiomelanocortin (POMC) neurons is sufficient to reduce food intake and body weight in Htr2cF327L/Y mice subjected to a high-fat diet (HFD).”
Reexpressing functional 5-HT2CR in POMC neurons reduces food intake and body weight
“We demonstrated that reexpressing functional 5-HT2CR solely in hypothalamic pro-opiomelanocortin (POMC) neurons is sufficient to reduce food intake and body weight in Htr2cF327L/Y mice subjected to a high-fat diet (HFD).”
Melanotan II administration suppresses feeding and weight gain
“Similarly, administration of melanotan II, an agonist of the melanocortin receptor 4 (MC4R), effectively suppresses feeding and weight gain in Htr2cF327L/Y mice.”
Promoting wheel-running activity decreases HFD consumption and improves glucose homeostasis
“Strikingly, promoting wheel-running activity in Htr2cF327L/Y mice results in a decrease in HFD consumption and improved glucose homeostasis.”
Source: PubMed 38815086 · DOI 10.1210/endocr/bqae063 · all study summaries